NZ314002A - A method of inhibiting inflammatory cytokine formation using polyprenyl derivatives - Google Patents

A method of inhibiting inflammatory cytokine formation using polyprenyl derivatives

Info

Publication number
NZ314002A
NZ314002A NZ314002A NZ31400294A NZ314002A NZ 314002 A NZ314002 A NZ 314002A NZ 314002 A NZ314002 A NZ 314002A NZ 31400294 A NZ31400294 A NZ 31400294A NZ 314002 A NZ314002 A NZ 314002A
Authority
NZ
New Zealand
Prior art keywords
inflammatory cytokine
inhibiting inflammatory
cytokine formation
polyprenyl derivatives
polyprenyl
Prior art date
Application number
NZ314002A
Inventor
Akikuni Yagita
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Priority claimed from NZ276178A external-priority patent/NZ276178A/en
Publication of NZ314002A publication Critical patent/NZ314002A/en

Links

Abstract

The specification describes the use of polyprenyl derivatives of formula (I) to treat ulcerative colitis.
NZ314002A 1993-12-01 1994-11-22 A method of inhibiting inflammatory cytokine formation using polyprenyl derivatives NZ314002A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP39975193 1993-12-01
NZ276178A NZ276178A (en) 1993-12-01 1994-11-22 Polyprenyl derivative as an antiinflammatory

Publications (1)

Publication Number Publication Date
NZ314002A true NZ314002A (en) 2000-11-24

Family

ID=26582868

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ314002A NZ314002A (en) 1993-12-01 1994-11-22 A method of inhibiting inflammatory cytokine formation using polyprenyl derivatives

Country Status (1)

Country Link
NZ (1) NZ314002A (en)

Similar Documents

Publication Publication Date Title
UA35592C2 (en) acetic acid Derivatives
MY111201A (en) New imidazopyridines
ZA945657B (en) Method to inhibit restenosis
MX9800411A (en) Cyclic gmp-specific phosphodiesterase inhibitors.
ZA955466B (en) Stereochemical wortmannin derivatives
MX9702488A (en) Purine and guanine compounds as inhibitors of pnp.
GB9210269D0 (en) Basin for burner which is produced by dishing
AU648907B2 (en) Corrosion inhibitors
AU563524B2 (en) Prostatic hyperlasia treatment by aromatase inhibitor
UA32529C2 (en) A method for purification of wastewater and a mechanism for realizing the same
JO1704B1 (en) New active compounds
GB9320785D0 (en) Dibenzylheterocyclic or dibenzylcycloalkyl derivatives as inhibitors of hiv intergrase
AU9066498A (en) Substituted 6-alkylphenanthridines
EP0118132A3 (en) A remedial or prophylactic agent for the treatment of seizures
GR3031602T3 (en) Novel 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase.
NZ314002A (en) A method of inhibiting inflammatory cytokine formation using polyprenyl derivatives
GR1002598B (en) Epi-epibatidine derivatives.
HU9401833D0 (en) Use of renin inhibitors for the treatment of glaucoma
HUT73637A (en) Use of hyaluronic acid and forms to prevent arterial restenosis
AP9600800A0 (en) 2-(Pyrazol-3-yl) carbapenem derivatives.
MX9603087A (en) Process to obtain substituted aminocarbonyltriazolinones.
TW342392B (en) Anomeric fluororibosyl amines
GB2333294A (en) Cytokine production inhibitors
EP0539987A3 (en) Process for the purification of crude alkalinic earth metal salts of n(5)-methyl-5,6,7,8-tetrahydrofolic acid
AP9400608A0 (en) "New nicotinic acid derivative".